Recent News

• 03.23.2026 - Beyond Breakthroughs: Expanding Access to CAR-T Through New Manufacturing Models
• 03.20.2026 - Frozen by Design: Expert Insights from the Live Q&A
• 03.04.2026 - Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
• 02.24.2026 - Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
• 02.09.2026 - Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
• 02.04.2026 - Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025

Recent Filings

• 03.04.2026 - EX-99.1 EX-99.1
• 03.04.2026 - 8-K Current report
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - 4/A Statement of changes in beneficial ownership of securities
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities